Ajit B Thakur

Title: Innovations by Ajit B Thakur in Pharmaceutical Science

Introduction

Ajit B Thakur, based in East Brunswick, NJ, is a talented inventor with an impressive portfolio of six patents. His contributions to pharmaceutical innovations focus on groundbreaking formulations that have significant implications for medical imaging and cancer treatment.

Latest Patents

Thakur's latest patents include "Adenosine derivative formulations for medical imaging," which outlines a stable composition that is beneficial for myocardial perfusion imaging using one or more 2-alkynyladenosine derivatives combined with a solvent made of water and hydroxypropyl-β-cyclodextrin. Another notable patent is centered around "Pharmaceutical compositions comprising N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide." This patent discloses various salts and crystalline forms of this compound, which is aimed at treating cancer and other proliferative diseases, alongside methods of preparation.

Career Highlights

Throughout his career, Thakur has been associated with esteemed organizations such as E.R. Squibb & Sons, Inc. and Bristol-Myers Squibb Company. His work has significantly influenced the field of pharmaceuticals, making strides toward innovative solutions in drug formulation and delivery.

Collaborations

Ajit B Thakur has had the opportunity to work alongside prominent colleagues in the industry, including Nemichand B Jain and Dilbir S Bindra. Such collaborations reflect his commitment to research and development in pharmaceutical sciences.

Conclusion

In summary, Ajit B Thakur's inventive contributions have propelled advancements in medical imaging and cancer treatment. His six patents serve as a testament to his expertise and commitment to improving health outcomes through innovative pharmaceutical formulations.